PATENT CLAIM ANALYSIS

Application Number: 16147153
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.

Claim (Index 45):
The pharmaceutical composition of  claim 39 , wherein the subject is a human, who is under about 18 years.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 97.0
- Lexical Diversity: 1.04
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15887523', '14788211', '15197209', '14079548', '15671653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7518932879977501
- 35 USC 102 Novelty (BERT): 0.6344258187205419
- Combined Prediction Score: 0.7401465410700293
- Mean Citation Score: 447.53735599999993
- Max Citation Score: 837.41754
- Similarity Product: 526.8244364098263

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test